Then Applied Biosystems (ABI) introduced its next-generation sequencing machine, which was quickly followed by instruments from Illumina and Roche 454.

In October 2007, Applied Biosystems announced availability of the ABI SOLiD system, the only commercial system that uses a ligation-based chemistry (see 'Applied Biosystems' approach to sequencing').

Their findings, published in the Proceedings of the National Academy of Sciences, pave the way for solid-state, label-free DNA sequencing technologies with implications for precision medicine.

Cancer cell monitoring startup Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with solid tumours.

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

Cancer cell monitoring startup Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with solid tumours. The company is based in ...

Applied Biosystems Announces Software Development Initiative for Next-Generation Sequencing Software Development Community expected to facilitate the advancement of bioinformatics applications for the ...

Applied Intuition’s raise comes just one year after it completed a $250 million Series E, which put the company at a $6 billion valuation. The company makes software that helps companies and ...

This article explores how next-generation sequencing has revolutionized microbiome research, enabling comprehensive analysis of microbial communities and their roles in health and disease.

Ampli1 LowPass Kit applications include the characterization and investigation of genomic heterogeneity and evolution in tumor cell populations such as individual circulating tumor cells (CTCs).